Hyalex Orthopaedics News
Hyalex Orthopaedics Announces FDA 510(k) Clearance of the HYALEX Slalom™ MTP Hemiarthroplasty System
- News, Press
Data from First-in-Human Clinical Studies of the Hyalex Freestyle Knee Implant to be Presented at the ICRS Congress 2025
- News, Press
Initial Results of Hyalex Freestyle Knee Implant First-in-Human Clinical Studies to be Presented at the ISAKOS Congress 2025
- News, Press
Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant
- News, Press
Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System
- News, Press
Hyalex Orthopaedics Appoints Thomas Vail, M.D., as Chief Medical Officer and Names Adam Gridley to Board of Directors
- News, Press
Hyalex VP of R&D Mary Beth Schmidt presents at ICRS World Congress 2022
- News, Press
Hyalex Welcomes Chris Cain as VP of Clinical and Regulatory Affairs
- News
Hyalex Orthopaedics appoints Carl Vause, orthopaedic industry veteran, as Chief Executive Officer and President; Names Mike Hawkins, PhD, Chief Technical Officer
- News
Hyalex Receives ISO 13485 Certification
- News, Press